GW24-e3561 Xuezhikang can reduce arterial stiffness in patients with essential hypertension, independent of lipid lowering effects | Heart

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Cardiovascular Disease Clinical Research

Related Pharmaceutical Clinical Research

GW24-e3561 Xuezhikang can reduce arterial stiffness in patients with essential hypertension, independent of lipid lowering effects

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Jin Z, Ping Y

GW24-e3561 Xuezhikang can reduce arterial stiffness in patients with essential hypertension, independent of lipid lowering effects

Heart 2013;99:A246.